BioCentury | Feb 8, 2018
Translation in Brief

Proteomic pathfinding

Biognosys is using a method developed by ETHZ researchers for the unbiased detection of molecular targets based on protein-metabolite interactions to study inter- and intra-patient variances in the proteome. The protein services CRO will also...
BioCentury | May 6, 2017

mDx blueprint

Thanks to a well-planned robust pivotal trial and a dose of good timing, Cologuard from Exact Sciences Corp. is enjoying one of the steepest launch trajectories of any molecular diagnostic. After 10 quarters of sales,...
Items per page:
1 - 2 of 2